FINWIRES · TerminalLIVE
FINWIRES

QXO's Planned Acquisition of TopBuild Seen as Accretive, Oppenheimer Says

By

-- QXO's (QXO) planned acquisition of TopBuild (BLD) for about $17 billion is incrementally positive and expected to be accretive, positioning the company as the leading distributor and installer of insulation and related building products in North America, Oppenheimer said in a Monday note.

The addition of TopBuild brings a premium asset with industry-leading margins and strong free cash flow conversion. The deal is expected to accelerate QXO's platform through pricing power, cross-selling opportunities, and the ability to leverage customer value chains and vendor relationships, the firm said.

Oppenheimer said it has built a pro-forma model combining QXO and TopBuild from 2024 through 2030, with 2030 estimates for revenue, adjusted EBITDA, and free cash flow of $35 billion, $5.5 billion, and $3.7 billion, respectively, all significantly above prior estimates.

The firm said the transaction is accretive on both earnings and free cash flow per share through 2030, adding that it expects lower near-term "reported" estimates for QXO from Q1 to Q3 due to challenging macro conditions.

Oppenheimer has an outperform rating on QXO and increased the company's price target to $32 from $30.

Price: $20.70, Change: $-0.27, Percent Change: -1.29%

Related Articles

Australia

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Research

Research Alert: Columbia Sportswear Company Beats Estimates; Raises Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:COLM posted Q1 2026 EPS of $0.65 vs. $0.75 prior year, $0.30 above consensus on flat net sales of $779M, $21M above estimates. International diversification proved valuable with EMEA surging 35% and LAAP growing 5%, offsetting a 10% U.S. decline, while gross margin contracted 20 bps to 50.7% primarily from a 310-bp incremental tariff impact. We believe the international growth strategy is effectively insulating the company from U.S. tariff headwinds and positioning it for sustained global expansion. Management raised full-year EPS guidance to $3.55-$4.00 from prior $3.20-$3.65 and operating margin guidance to 6.7%-7.5% reflecting better tariff conditions. The company maintains its fortress balance sheet with $535.4M cash and no debt while executing a $150M share repurchase program. We are impressed with international performance driving growth and expect continued momentum from the ACCELERATE Growth Strategy targeting younger consumers, with shares trading at 17x forward EPS guidance.

$COLM
Mining & Metals

Fairfax India Holdings Corp Announcing FY25 Net Earnings of US$410.5M or $3.05 Net Earnings Per Diluted Share

$FIH-U.TO